Zobrazeno 1 - 10
of 2 460
pro vyhledávání: '"S. A. Vladimirov"'
Ocherki Istorii Russkoi Sovetskoi Dramaturgii. Vol. 1: 1917-1934. S. V. Vladimirov D. I. Zolotnitsky
Autor:
Lehrman, Edgar H.
Publikováno v:
Slavic Review, 1972 Mar 01. 31(1), 200-202.
Externí odkaz:
https://www.jstor.org/stable/2494197
Autor:
Robert L. Merlino
Publikováno v:
Journal of Plasma Physics. 75:709-711
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4d2c815e6c5befa1e5e04f34c1ac086
https://doi.org/10.1017/s0022377809990225
https://doi.org/10.1017/s0022377809990225
Autor:
S. A. Vladimirov, M. S. Eliseev
Publikováno v:
Научно-практическая ревматология, Vol 56, Iss 6, Pp 746-752 (2019)
The paper considers currently available drugs used to treat calcium pyrophosphate crystal deposition disease. It discusses the advantages and disadvantages of the most widely used drugs, such as nonsteroidal anti-inflammatory drugs, colchicine, gluco
Externí odkaz:
https://doaj.org/article/1d3310bd47f24b63bab84761a82118b8
Publikováno v:
Научно-практическая ревматология, Vol 56, Iss 2, Pp 196-201 (2018)
Objective: to compare the efficacy of methotrexate (MTX) and colchicine in patients with chronic arthritis in calcium pyrophosphate crystal deposition disease (CPPDD).Subjects and methods. Data from a controlled prospective cross-sectional study of 1
Externí odkaz:
https://doaj.org/article/a61b65266fbe4a1aac4966fb1a8584b4
Publikováno v:
Современная ревматология, Vol 11, Iss 4, Pp 83-88 (2018)
Gout is a chronic disease that requires permanent urate-lowering therapy. Allopurinol is the gold standard of this therapy. The novel drug febuxostat, a selective xanthine oxidase inhibitor, has been synthesized and introduced into clinical practice
Externí odkaz:
https://doaj.org/article/9d9786cb42254dcfaf4058152fb2a88c
Autor:
S. V. Vladimirov, O. Ishihara
Publikováno v:
Advances in Physics: X, Vol 2, Iss 2, Pp 462-480 (2017)
The electromagnetic wave propagation in a complex plasma containing macroparticle inclusions (dust) is reviewed. We focus on two classes of phenomena due to the presence of dust: (1), collection of plasma electrons and ions by macroparticle inclusion
Externí odkaz:
https://doaj.org/article/b2efbf9a90c248338f83092bb657a327
Autor:
Z. M. SIZOVA, S .K. VLADIMIROV
Publikováno v:
Медицинский совет, Vol 0, Iss 13, Pp 38-43 (2016)
Results of meta-analysis of more than 20 clinical studies of use of various dosages and schemes of indication of trimetazidine to stable ischemic heart disease patients allowed considering the daily dosage of trimetazidine 70 mg as a standard therape
Externí odkaz:
https://doaj.org/article/76fb224829ae40398ddb1905cef06d3d
Autor:
E. L. Nasonov, D. E. Karateev, A. M. Satybaldyev, E. L. Luchikhina, G. V. Lukina, M. V. Nikolenko, V. A. Bilinskaya, M. E. Dmitrieva, L. A. Bogoderova, N. A. Lapkina, N. V. Chichasova, V. N. Sorotskaya, D. I. Abdulganieva, R. G. Mukhina, G. R. Gafurov, V. I. Mazurov, D. S. Chakieva, R. R. Samigullina, E. G. Kuznetsova, N. V. Demidova, N. Yu. Nikishina, E. V. Fedorenko, E. V. Gerasimova, E. A. Zlepko, N. V. Muravyeva, G. I. Gridneva, O. A. Rumyantseva, K. A. Kasumova, A. V. Alekseeva, N. S. Shornikova, S. A. Vladimirov, D. A. Gukasyan, L. N. Tyurina, L. N. Denisov, T. G. Oskilko, E. A. Koshkarova
Publikováno v:
Научно-практическая ревматология, Vol 54, Iss 0, Pp 50-62 (2016)
The paper presents the materials of the Russian Arthritis Registry (OREL) that includes 3276 patients from 11 Russian Federation's largest research-and-practical centers situated in Moscow, Saint Petersburg, Novosibirsk, Kazan, Tula, Yaroslavl, Tyume
Externí odkaz:
https://doaj.org/article/0cb643757d78490a94ac57ea6018ea94
Autor:
I G Kirillova, D S Novikova, T V Popkova, E N Aleksandrova, A A Novikov, Yu N Gorbunova, E I Markelova, Yu O Korsakova, S I Glukhova, A V Volkov, E L Luchikhina, N V Demidova, K A Kasumova, S A Vladimirov, M A Kanonirova, G L Lukina, D E Karateev, E L Nasonov
Publikováno v:
Терапевтический архив, Vol 88, Iss 5, Pp 19-26 (2016)
Aim. To determine N-terminal pro-brain natriuretic peptide (NT-proBNP) levels in patients with early rheumatoid arthritis (RA) before the use of disease-modifying antirheumatic drugs (DMARDs); to compare NT-proBNP values with traditional risk factors
Externí odkaz:
https://doaj.org/article/f7c1e68a78364be78a49b432ab41d573
Autor:
M. S. Eliseev, O. V. Zhelyabina, E. I. Markelova, D. S. Novikova, S. A. Vladimirov, Yu. O. Korsakova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov
Publikováno v:
Современная ревматология, Vol 10, Iss 1, Pp 7-14 (2016)
It is suggested that interleukin (IL)-1β inhibition may promote a reduction in the risk of cardiovascular diseases; however, the mechanism of this impact has not been adequately investigated.Objective: to evaluate the impact of canakinumab therapy o
Externí odkaz:
https://doaj.org/article/b520f047e9d44f0390b434c9f8f601d1